Compare Google Inc (GOOG) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Google Inc vs Kymera Therapeutics Inc. Common Stock — how do they compare? Google Inc trades at $338.72 (market cap $4.30T), while Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B). The key difference: Google Inc is far larger — about 484.8× Kymera Therapeutics Inc. Common Stock's market cap, and Google Inc pays a 0.25% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Google Inc for 138 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| GOOG | KYMR | |
|---|---|---|
Market Cap | $4.30T | $8.87B |
Volume | 14,394,061 | 779,107 |
Sector | Media | Health |
52-Week High | $399.06 | $127.31 |
52-Week Low | $251.34 | $55.80 |
Typical Hold Time | 138 Days | 0 Days |
Enterprise Value | $4.19T | $8.26B |
Dividend Yield | 0.25% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Alphabet (GOOG) trades at $349.52, up 0.16% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust revenue growth to $402.84 billion in 2025, with net income surging to $132.17 billion and a net margin of 32.8%. Recent earnings beats and a consensus analyst price target of $435.29 highlight investor confidence, though high capital expenditures and legal challenges present near-term risks.
The outlook for GOOG remains positive driven by AI and cloud expansion, with projected 2026 revenue of $445.9 billion. However, rising capex leading to negative free cash flow projections and ongoing securities lawsuits pose significant risks. The stock's current valuation metrics, including a P/E of 17.54, suggest room for growth if execution continues, but investors should weigh these factors against the competitive and regulatory landscape.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Google Inc
Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Read more on GOOG →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
